...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Transfer of ZEN from RBC DI to TFSA

This topic has taken on a life of its own, and I've been following on all of the helpful considerations and pros/cons. As an update, I am still committed to finding the right person at RBC DI -- so far they are telling me it can't be done. But based on some recommendations I have a couple of more specific people to approach. I'll be happy to share with the group if/when I have success to share.

 

- Canuck19

Share
New Message
Please login to post a reply